Management of bleeding following major trauma: an updated European guideline
Abstract
Abstract Introduction Evidence-based recommendations are needed to guide the acute management of the bleeding trauma patient, which when implemented may improve patient outcomes. Methods The multidisciplinary Task Force for Advanced Bleeding Care in Trauma was formed in 2005 with the aim of developing a guideline for the management of bleeding following severe injury. This document presents an updated version of the guideline published by the group in 2007. Recommendations were formulated using a nominal group process, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) hierarchy of evidence and based on a systematic review of published literature. Results Key changes encompassed in this version of the guideline include new recommendations on coagulation support and monitoring and the appropriate use of local haemostatic measures, tourniquets, calcium and desmopressin in the bleeding trauma patient. The remaining recommendations have been reevaluated and graded based on literature published since the last edition of the guideline. Consideration was also given to changes in clinical practice that have taken place during this time period as a result of both new evidence and changes in the general availability of relevant agents and technologies. Conclusions This guideline provides an evidence-based multidisciplinary approach to the management of critically injured bleeding trauma patients.
Funding
- National Science Foundation
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- B. Braun Melsungen
- CSL Behring
- Stryker
- Swiss Foundation for Anesthesia Research
- Société Suisse d'Anesthésie et Réanimation
- National Institute for Health and Care Research
- College of Emergency Medicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Secrétariat Général pour les Affaires Régionales, Etat en Région Aquitaine
- Novo Nordisk
- Astellas Pharma
- Universität Zürich
- European Society of Anaesthesiology
- Olga Mayenfisch Stiftung
- Swiss Life Stiftung für Chancenreichtum und Zukunft
- European Society of Intensive Care Medicine
- Cilag
How this paper connects to the literature. Drag to explore, click any node to open that paper.
